Please login to the form below
rheumatoid arthritis
This page shows the latest rheumatoid arthritis news and features for those working in and with pharma, biotech and healthcare.
AbbVie’s Rinvoq approved by EC for Crohn's disease
The therapy is also already approved in the EU for adults with radiographic axial spondyloarthritis, non-radiographic axial spondyloarthritis, psoriatic arthritis, rheumatoid arthritis and ulcerative colitis, as well as for adults
Latest news
-
Sandoz’s biosimilar denosumab application accepted by FDA for osteoporosis
The recommendation comprises all indications covered by the reference medicine, including Crohn’s disease, plaque psoriasis, ulcerative colitis, rheumatoid arthritis and uveitis.
-
Sandoz’s high concentration Hyrimoz formulation recommended for use in EU
The recommendation includes multiple indications such as rheumatoid arthritis and Crohn’s disease. ... adalimumab). The recommendation comprises all indications covered by the reference medicine, including Crohn’s disease, plaque psoriasis,
-
Gilead and EVOQ Therapeutics partner in deal potentially worth over $650m
The companies will focus on developing therapies for rheumatoid arthritis and lupus. ... Gilead and EVOQ Therapeutics (EVOQ) have entered into a collaboration and licensing agreement aimed at advancing immunotherapies for the treatment of rheumatoid
-
Roche’s COVID-19 antibody receives FDA approval for hospitalised adults
Like Actemra, which was approved in 2010 to treat rheumatoid arthritis, Kineret has been on the US market for more than two decades for the treatment of RA, and has been
-
AbbVie receives extended SMC recommendation for Rinvoq in rheumatoid arthritis patients
AbbVie’s Rinvoq (upadacitinib) has been accepted by the Scottish Medicines Consortium (SMC) as a treatment for moderate-to-severe active rheumatoid arthritis (RA).
More from news
Approximately 61 fully matching, plus 470 partially matching documents found.
Latest Intelligence
-
Biosimilars and beyond: innovating for improved patient outcomes
profile. Biosimilars are used to treat a vast range of conditions, including chronic diseases such as rheumatoid arthritis, as well as certain types of cancers.
-
The importance of value when treating patients
These cost restrictions have significant effects: people living with rheumatoid arthritis or psoriatic arthritis saw reduced treatment effectiveness and therapy adherence while on a step therapy programme compared with those without.
-
Looking to the future of patient empowerment
By Max Noble. Patients, or should we say people, with conditions such as asthma, rheumatoid arthritis and lupus have never had as much access to medical information as they do today.
-
Building a brighter future with patient support programmes
Take someone with rheumatoid arthritis. They may be on several medications yet one company will only support through their drug,” said Noble.
-
Setting up for success in a post-Brexit, post-pandemic Britain
and Rheumatoid Arthritis (RA). ... people with moderate as well as severe rheumatoid arthritis – aiming to avoid irreversible damage as early as possible.
More from intelligence
Approximately 0 fully matching, plus 47 partially matching documents found.
Latest appointments
-
Portland Health appoints Jamie Hewitt as an account director
He joins the firm from the National Rheumatoid Arthritis Society, where he was its head of government affairs, leading the policy and public affairs functions. ... During his time at the National Rheumatoid Arthritis Society, Hewitt ran UK campaigns to
-
Liberation Unlimited promotes Vicky Smith
oncology, rheumatoid arthritis and eye health.
-
Galapagos appoints Bart Filius as chief financial officer
His vast experience in big pharma and his sharp strategic view will help us bring Galapagos to the next level, as we prepare to have our rheumatoid arthritis molecule GLPG0634 enter
-
TiGenix appoints Dr Marie Paule Richard
In her new role Richard will be responsible for the development of several products in Europe and the US, including rheumatoid arthritis and severe sepsis candidate Cx611 and Cx601, which is
-
Liberation promotes Danielle Smith to account director
Meanwhile, Vicky joined Liberation last year and in her new role will continue to work across a range of therapeutic areas including men's health, rheumatoid arthritis and eye health.
More from appointments
Approximately 1 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
What does the future hold for clinical trial recruitment?
For example, new commonalities have been discovered between Type 1 diabetes, lupus, multiple sclerosis and rheumatoid arthritis, suggesting that drugs already in use to treat one autoimmune disease could be equally
-
Covid-19: how is it affecting prescribing patterns?
In this article, we will examine three key disease areas: COPD, rheumatoid arthritis and multiple sclerosis to determine which drug types have been the winners and losers in terms of usage ... Rheumatoid arthritis. Rheumatoid arthritis has seen a
-
The other side of … rheumatoid arthritis
The other side of … rheumatoid arthritis. “I harassed my GP enough to get it caught early”. ... Meet Georgie. At age 26, Georgie was diagnosed with rheumatoid arthritis, an autoimmune inflammatory condition that affects up to 1% of the population
-
Lucid Group reaches the finals of the PM360 2020 Trailblazer Initiative Awards
Lucid Group has been named as a finalist in the PM360 2020 Trailblazer Initiative Awards in the HCP Education category, for the program LiBRA 2019: Looking beyond the joint in rheumatoid ... arthritis (RA): Is there a missing link in RA management?
-
Lucid Group scoop a win and a high commendation at Communiqué 2020
Its programme – ‘LiBRA 2019: Looking beyond the joint in rheumatoid arthritis (RA): Is there a missing link in RA management?’ – won the category, with a high commendation going to ‘CLEAR HORIZONS – ... We were thrilled that our work in both
More from PMHub
Approximately 8 fully matching, plus 19 partially matching documents found.
Subscribe to our email news alerts
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Sanofi's frexalimab shows promise in relapsing forms of MS
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Amgen reports positive results for Otezla in psoriatic arthritis
- Medscape Education is Focusing on Patient Centricity and Education Outcomes at EHA 2023
- Pfizer reports positive results for elranatamab in multiple myeloma
- Amgen’s Lumakras shows promise in phase 3 lung cancer study
- Adaptive innovation
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- Navigating patients step by step on their clinical trial journey
No results were found
PMHub
Create Health
A specialist Advertising and Med Comms agency dedicated to bringing much-needed creativity to healthcare marketing. We believe that brilliant ideas...
Latest intelligence
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
- Tuberculosis – why it remains a major global public health challenge
- Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
- Whitepaper: Closing the gap with compelling healthcare communications
- Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
